Because the J20 model shares many features with AD patients [60], in which BACE1 inhibitors also failed to prevent or slow cognitive decline [33, 34], the inability of BACEi to reduce functional abnormalities in J20 mice could be interpreted as high predictive value of the model. Here, BACE1 is linked to Alzheimer disease.